Andras Koser — Greenville, South Carolina

Andras Koser is a clinical research site located in Greenville, South Carolina, United States 29615.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Andras Koser has participated in 1 clinical trials.

Therapeutic areas: Influenza.

Sponsors: BioCryst Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Greenville

Browse all research sites in South Carolina · View every site in Greenville

• University Medical Group
• Bon Secours Saint Francis Hospital
• Greenville Hospital System Medical Center
• Vascular Health Alliance, Greenville Hospital System
• Patewood Memorial Hospital
• Upstate Cardiothoracic Surgery, Greenville Hospital System
• University of South Carolina Greenville / Prisma Health-Upstate
• Greenville Hospital System University Medical Group
• Shriners Hospitals for Children
• NorthShore University HealthSystem
• Greenville Hospital System University Medical Center (ITOR) - Upstate Affiliate Organization
• University of South Carolina School of Medicine

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Andras Koser?

Andras Koser has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Andras Koser conducted?

Andras Koser has 1 clinical trials on record. Their work covers Influenza.

Is Andras Koser accredited by Crixeo Clinical Trials?

Andras Koser has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Andras Koser?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.